5-Amino-1MQ 500mcg 90 Capsules
5-Amino-1MQ is a small-molecule compound studied in preclinical settings for its interaction with NNMT-related pathways and cellular metabolism models. Precision-focused. Structured for laboratory research. For laboratory research only.
MaxCut 999mcg 90 Capsules
RYZN Research Stack combines BPC-157, SLU-PP-332, and Tesofensine—three compounds commonly explored across tissue signaling, energy-regulation pathways, and neurotransmitter-linked mechanisms in controlled models.
BPC-157 1000mcg 90 Capsules
BPC-157 (Body Protection Compound-157) is a naturally derived research peptide that has been studied for its potential role in supporting cellular repair and maintaining a healthy gastrointestinal environment. Early research suggests it may help promote tissue recovery and reduce localized inflammation through modulation of growth and repair pathways. Oral formulations are being explored for stability and systemic effects related to gut integrity and overall wellness.
Tesofensine 1000mcg 90 Capsules
Tesofensine is a small-molecule research compound studied for its interactions with monoaminergic neurotransmitter systems (serotonin, norepinephrine, and dopamine) in controlled models. It’s commonly explored in research examining appetite- and energy-balance signaling pathways.
SLU-PP-332 1000mcg 90 Capsules
SLU-PP-332 is an experimental research compound explored in preclinical models focused on energy-regulation and metabolic signaling. Often referenced in studies evaluating exercise-mimetic pathway activity in controlled settings.
Dihexa 90 Capsules - Extended Release
Dihexa (PNB-0408) is a peptide-derived research compound studied in preclinical and in-vitro models for its relationship to HGF/c-Met signaling and synaptic-pathway investigation. Built for controlled laboratory research. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke.





